Pharm-话题@MedSci

#Pharm#

730篇内容 | 2547人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1787814, encodeId=1d7e1e878141e, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Hum Psychopharmacol：高剂量VitB6可能缓解焦虑和抑郁, objectType=article, longId=732858, objectId=c727e3285845, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c727e3285845, replyNumber=0, likeNumber=117, createdTime=2022-09-21, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c727e3285845, moduleTitle=Hum Psychopharmacol：高剂量VitB6可能缓解焦虑和抑郁, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c727e3285845)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787806, encodeId=fa311e8780659, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Front Pharmacol：中草药对特发性膜性肾病 (REACH-MN) 的影响, objectType=article, longId=729650, objectId=c924e2965071, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c924e2965071, replyNumber=0, likeNumber=126, createdTime=2022-08-07, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c924e2965071, moduleTitle=Front Pharmacol：中草药对特发性膜性肾病 (REACH-MN) 的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c924e2965071)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787795, encodeId=cea41e8779522, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=J Ethnopharmacol：中医药治疗慢传输型便秘的研究进展, objectType=article, longId=726623, objectId=b9e1e2662315, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9e1e2662315, replyNumber=0, likeNumber=91, createdTime=2023-03-24, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9e1e2662315, moduleTitle=J Ethnopharmacol：中医药治疗慢传输型便秘的研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9e1e2662315)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787760, encodeId=72e91e87760cf, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Rhizen Pharmaceuticals AG宣布，在一项有关使用其新型PARP抑制剂(RP12146)治疗晚期实体瘤的I/Ib期研究中进行了首例患者给药, objectType=article, longId=219842, objectId=267d219842d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=267d219842d5, replyNumber=0, likeNumber=78, createdTime=2022-02-15, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=267d219842d5, moduleTitle=Rhizen Pharmaceuticals AG宣布，在一项有关使用其新型PARP抑制剂(RP12146)治疗晚期实体瘤的I/Ib期研究中进行了首例患者给药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=267d219842d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787800, encodeId=9c5c1e87800ef, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=J Ethnopharmacol：基于“入血清成分-作用靶点关键途径”分析法预测大承气汤治疗大肠癌的机制, objectType=article, longId=728084, objectId=c0fbe2808456, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0fbe2808456, replyNumber=0, likeNumber=83, createdTime=2022-10-15, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0fbe2808456, moduleTitle=J Ethnopharmacol：基于“入血清成分-作用靶点关键途径”分析法预测大承气汤治疗大肠癌的机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0fbe2808456)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787777, encodeId=6ae91e87777fb, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Eur Rev Med Pharmacol Sci：在意大利COVID-19大流行封锁期间，艾多沙班治疗狼疮抗凝物阳性患者静脉血栓栓塞/肺栓塞的真实世界研究, objectType=article, longId=299655, objectId=33a02996554c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33a02996554c, replyNumber=0, likeNumber=82, createdTime=2022-05-05, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33a02996554c, moduleTitle=Eur Rev Med Pharmacol Sci：在意大利COVID-19大流行封锁期间，艾多沙班治疗狼疮抗凝物阳性患者静脉血栓栓塞/肺栓塞的真实世界研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33a02996554c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787753, encodeId=e41b1e8775357, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Br J Pharmacol:丁酸盐通过增强肠道屏障功能和FFA2介导的PI3K/AKT/mTOR信号通路改善糖尿病肾病骨骼肌萎缩, objectType=article, longId=218682, objectId=875c218682b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=875c218682b2, replyNumber=0, likeNumber=65, createdTime=2021-10-26, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=875c218682b2, moduleTitle=Br J Pharmacol:丁酸盐通过增强肠道屏障功能和FFA2介导的PI3K/AKT/mTOR信号通路改善糖尿病肾病骨骼肌萎缩, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=875c218682b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787771, encodeId=aa701e87771e3, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Pharmacol Res：GIP和GLP-2共同改善支持GIPR-GLP-2R共激动剂作为未来骨质疏松症治疗的人类骨转换, objectType=article, longId=294731, objectId=07dc294e315d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07dc294e315d, replyNumber=0, likeNumber=86, createdTime=2022-10-13, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07dc294e315d, moduleTitle=Pharmacol Res：GIP和GLP-2共同改善支持GIPR-GLP-2R共激动剂作为未来骨质疏松症治疗的人类骨转换, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07dc294e315d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787789, encodeId=d3bb1e8778946, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Pharmacol Res：四妙勇安汤(SMYAD)的主要活性成分通过PDE5A-AKT和TLR4-NOX4通路在异丙肾上腺素(ISO)诱导的心力衰竭模型中抑制自噬和凋亡, objectType=article, longId=724691, objectId=cf36e2469145, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf36e2469145, replyNumber=0, likeNumber=78, createdTime=2023-03-05, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf36e2469145, moduleTitle=Pharmacol Res：四妙勇安汤(SMYAD)的主要活性成分通过PDE5A-AKT和TLR4-NOX4通路在异丙肾上腺素(ISO)诱导的心力衰竭模型中抑制自噬和凋亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf36e2469145)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787742, encodeId=b5761e87742a7, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=临床调查显示Herb-Pharma的ViroStop喷雾剂可有效减轻新冠肺炎影响, objectType=article, longId=217586, objectId=13ff21e586d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13ff21e586d9, replyNumber=0, likeNumber=97, createdTime=2021-11-26, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13ff21e586d9, moduleTitle=临床调查显示Herb-Pharma的ViroStop喷雾剂可有效减轻新冠肺炎影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13ff21e586d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787767, encodeId=4fdb1e87767dd, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Pharm Biol：老祖宗诚不我欺！百合通过调节肠道菌群和代谢，安神助眠！, objectType=article, longId=293996, objectId=3ba62939963e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ba62939963e, replyNumber=0, likeNumber=79, createdTime=2022-06-06, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ba62939963e, moduleTitle=Pharm Biol：老祖宗诚不我欺！百合通过调节肠道菌群和代谢，安神助眠！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ba62939963e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787739, encodeId=e9471e87739c7, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Noxopharm的临床前数据进一步支持Idronoxil在新冠肺炎治疗中的抗炎作用, objectType=article, longId=216393, objectId=9575216393a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9575216393a0, replyNumber=0, likeNumber=71, createdTime=2022-05-03, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9575216393a0, moduleTitle=Noxopharm的临床前数据进一步支持Idronoxil在新冠肺炎治疗中的抗炎作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9575216393a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787745, encodeId=1a0f1e87745fa, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Br J Clin Pharmacol：与维生素K拮抗剂相比，直接口服抗凝剂在COVID-19心脏代谢疾病门诊患者中的功效与安全性, objectType=article, longId=217655, objectId=0a9721e65504, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a9721e65504, replyNumber=0, likeNumber=75, createdTime=2022-02-23, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a9721e65504, moduleTitle=Br J Clin Pharmacol：与维生素K拮抗剂相比，直接口服抗凝剂在COVID-19心脏代谢疾病门诊患者中的功效与安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a9721e65504)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787770, encodeId=c6911e877709b, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Clin Pharmacol Ther:Secukinumab治疗银屑病的创新儿科开发之路, objectType=article, longId=294274, objectId=fe2d2942e48c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe2d2942e48c, replyNumber=0, likeNumber=76, createdTime=2022-06-24, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe2d2942e48c, moduleTitle=Clin Pharmacol Ther:Secukinumab治疗银屑病的创新儿科开发之路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe2d2942e48c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787750, encodeId=62881e87750af, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Clin Pharmacol Ther ：2型糖尿病患者中GLP-1 RA和DPP-4抑制剂的使用与肠梗阻风险增加相关, objectType=article, longId=218302, objectId=3ada21830258, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ada21830258, replyNumber=0, likeNumber=74, createdTime=2022-01-21, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ada21830258, moduleTitle=Clin Pharmacol Ther ：2型糖尿病患者中GLP-1 RA和DPP-4抑制剂的使用与肠梗阻风险增加相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ada21830258)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787788, encodeId=38011e8778830, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Front Pharmacol：疏肝和胃汤改善慢性应激模型大鼠抑郁、焦虑样行为——调节盲肠菌群和抑制NLRP3炎症小体减轻盲肠黏膜损伤, objectType=article, longId=724608, objectId=7c5de2460814, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c5de2460814, replyNumber=0, likeNumber=66, createdTime=2023-02-24, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c5de2460814, moduleTitle=Front Pharmacol：疏肝和胃汤改善慢性应激模型大鼠抑郁、焦虑样行为——调节盲肠菌群和抑制NLRP3炎症小体减轻盲肠黏膜损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c5de2460814)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787741, encodeId=b8991e87741e9, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=British journal of clinical pharmacology：STEMI溶栓·大家谈｜王智勇：肝素化是溶栓时进行还是溶栓后进行？哪种方案更好？, objectType=article, longId=217506, objectId=e18d21e50675, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e18d21e50675, replyNumber=0, likeNumber=96, createdTime=2022-02-27, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e18d21e50675, moduleTitle=British journal of clinical pharmacology：STEMI溶栓·大家谈｜王智勇：肝素化是溶栓时进行还是溶栓后进行？哪种方案更好？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e18d21e50675)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787759, encodeId=12b71e8775974, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Pharm Biol：黄芪多糖抗肝细胞癌的机制研究, objectType=article, longId=219769, objectId=db8c219e69d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db8c219e69d4, replyNumber=0, likeNumber=108, createdTime=2022-05-08, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db8c219e69d4, moduleTitle=Pharm Biol：黄芪多糖抗肝细胞癌的机制研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db8c219e69d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787757, encodeId=7bc21e8775799, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Front Pharmacol：进展性间质性纤维化肺病的死亡率预测因子, objectType=article, longId=219584, objectId=57e1219584d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57e1219584d4, replyNumber=0, likeNumber=106, createdTime=2022-04-23, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57e1219584d4, moduleTitle=Front Pharmacol：进展性间质性纤维化肺病的死亡率预测因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57e1219584d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787787, encodeId=fec21e8778757, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Front Pharmacol：四妙勇安汤治疗糖尿病视网膜病变的网络药理学与体内结合研究, objectType=article, longId=724296, objectId=92f6e24296f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92f6e24296f3, replyNumber=0, likeNumber=75, createdTime=2022-06-28, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92f6e24296f3, moduleTitle=Front Pharmacol：四妙勇安汤治疗糖尿病视网膜病变的网络药理学与体内结合研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92f6e24296f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Pharm

2020-05-29

仁者大医 (审核中...)

前往app查看评论内容

#Pharm#

Hum Psychopharmacol：高剂量VitB6可能缓解焦虑和抑郁

2022-09-21

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Front Pharmacol：中草药对特发性膜性肾病 (REACH-MN) 的影响

2022-08-07

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

J Ethnopharmacol：中医药治疗慢传输型便秘的研究进展

2023-03-24

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Rhizen Pharmaceuticals AG宣布，在一项有关使用其新型PARP抑制剂(RP12146)治疗晚期实体瘤的I/Ib期研究中进行了首例患者给药

2022-02-15

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

J Ethnopharmacol：基于“入血清成分-作用靶点关键途径”分析法预测大承气汤治疗大肠癌的机制

2022-10-15

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Eur Rev Med Pharmacol Sci：在意大利COVID-19大流行封锁期间，艾多沙班治疗狼疮抗凝物阳性患者静脉血栓栓塞/肺栓塞的真实世界研究

2022-05-05

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Br J Pharmacol:丁酸盐通过增强肠道屏障功能和FFA2介导的PI3K/AKT/mTOR信号通路改善糖尿病肾病骨骼肌萎缩

2021-10-26

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Pharmacol Res：GIP和GLP-2共同改善支持GIPR-GLP-2R共激动剂作为未来骨质疏松症治疗的人类骨转换

2022-10-13

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Pharmacol Res：四妙勇安汤(SMYAD)的主要活性成分通过PDE5A-AKT和TLR4-NOX4通路在异丙肾上腺素(ISO)诱导的心力衰竭模型中抑制自噬和凋亡

2023-03-05

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

临床调查显示Herb-Pharma的ViroStop喷雾剂可有效减轻新冠肺炎影响

2021-11-26

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Pharm Biol：老祖宗诚不我欺！百合通过调节肠道菌群和代谢，安神助眠！

2022-06-06

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Noxopharm的临床前数据进一步支持Idronoxil在新冠肺炎治疗中的抗炎作用

2022-05-03

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Br J Clin Pharmacol：与维生素K拮抗剂相比，直接口服抗凝剂在COVID-19心脏代谢疾病门诊患者中的功效与安全性

2022-02-23

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Clin Pharmacol Ther:Secukinumab治疗银屑病的创新儿科开发之路

2022-06-24

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Clin Pharmacol Ther ：2型糖尿病患者中GLP-1 RA和DPP-4抑制剂的使用与肠梗阻风险增加相关

2022-01-21

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Front Pharmacol：疏肝和胃汤改善慢性应激模型大鼠抑郁、焦虑样行为——调节盲肠菌群和抑制NLRP3炎症小体减轻盲肠黏膜损伤

2023-02-24

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

British journal of clinical pharmacology：STEMI溶栓·大家谈｜王智勇：肝素化是溶栓时进行还是溶栓后进行？哪种方案更好？

2022-02-27

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Pharm Biol：黄芪多糖抗肝细胞癌的机制研究

2022-05-08

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Front Pharmacol：进展性间质性纤维化肺病的死亡率预测因子

2022-04-23

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Front Pharmacol：四妙勇安汤治疗糖尿病视网膜病变的网络药理学与体内结合研究

2022-06-28

科室
- - 订阅+
  - 更多科室
工具
服务